Physicians

eviti – A Breakthrough Solution

The eviti cancer care decision-support platform was first introduced in October 2010 by eviti, Inc. (formerly known as ITA Partners). eviti provides a breakthrough solution that addresses the increasingly challenging and complex cancer crisis by empowering physicians with oncology information and evidence-based cancer treatment options.

eviti is the Most Comprehensive, Advanced
Cancer Care Platform Available Today

eviti provides both software and clinical services and is backed by an extensive clinical library compiled and managed by expert oncologists. Its comprehensive oncology information, guidelines to cancer pathways and evidence-based standards are derived from journals, scientific literature and reputable oncology organizations.

eviti’s Success Lies in its Many Robust Features

eviti’s robust platform features empower physicians to provide the best quality, cost-effective care for their patients:

• Comprised of over 1,200 nationally accepted treatment regimens
• Covers all modalities for more than 120 cancer types
• Includes access to thousands of clinical trials including all federally sponsored studies
• Equips physicians with verified, collaborative, evidence-based standards and comprehensive oncology solutions
• Provides real-time accessibility and actionable information for fast, informed, treatment plan review and decisions
• Takes into consideration outcomes, toxicities, costs and efficacy
• Offers independent, unbiased treatment guidelines compiled by unprejudiced top oncologists with over a decade of cancer disease management experience
• Facilitates timely reimbursement from insurance companies assured of optimum, cost-effective care
• Aligns with insurance plan language to help expedite payments

eviti is the most comprehensive, oncology decision-making platform for fighting cancer today. eviti provides a transformative decision-support solution to the cancer crisis by empowering physicians with advanced oncology decision support – well beyond clinical pathways. In the end, physicians have access to proven cancer treatment plans, total cancer care costs are reduced, and patients receive the best and most affordable cancer treatment support available.